LXRX
NASDAQ · Pharmaceuticals
Lexicon Pharmaceuticals Inc
$2.05
+0.02 (+0.74%)
Open$2.04
Previous Close$2.04
Day High$2.06
Day Low$1.99
52W High$2.68
52W Low$1.06
Volume—
Avg Volume2.18M
Market Cap892.14M
P/E Ratio—
EPS$-0.15
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
+776.6% upside
Current
$2.05
$2.05
Target
$17.97
$17.97
$15.16
$17.97 avg
$22.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 61.20M | 68.34M | 62.90M |
| Net Income | -61,869,677 | 19.40M | 18.23M |
| Profit Margin | -101.1% | 28.4% | 29.0% |
| EBITDA | -59,327,087 | 29.54M | 28.34M |
| Free Cash Flow | — | 10.65M | 12.86M |
| Rev Growth | +692.7% | +10.7% | +9.3% |
| Debt/Equity | 0.50 | 0.92 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |